Identification of major metabolites in rat urine and plasma of N6-(4-hydroxybenzyl) adenine riboside by LC/MS/MS

Biomedical Chromatography

Volumn 25, Issue 3, 2011, Pages 344-352

  Lei, Yujia ^a   Wang, Li ^a   Cheng, Mengchun ^a   Xiao, Hongbin ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Gastrodia elata; LC MS MS; Metabolism; Metabolite identification

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; METABOLITES; PHYSIOLOGY; RATS;

GASTRODIA ELATUM; LC-MS-MS; LC.MS/MS; METABOLITE IDENTIFICATION; PARENT COMPOUNDS; PHASE I; PHASE II; RAT PLASMA; RAT URINE; RIBOSIDES;

METABOLISM;

DRUG METABOLITE; N 6 (4 HYDROXYBENZYL)ADENINE RIBOSIDE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG SULFATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; RAT; URINALYSIS;

GASTRODIA ELATA; RATTUS;

EID: 79951526333     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1452     Document Type: Article

References (12)

1. Appolpnova SA, Shpak AV and Semenov VA. Liquid chromatography-electrospray ionization ion trap mass spectrometry for analysis of mesocarb and its metabolites in human urine. Journal of Chromatography B 2004; 800: 281-289.
2. Chan W, Cui L, Xu GW and Cai ZW. Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2006; 20: 1755-1760.
3. Hakala KS, Link M, Szotakova B, Skalova L, Kostiainen R and Ketola RA. Characterization of metabolites of sibutramine in primary cultures of rat hepatocytes by liquid chromatography-ion trap mass spectrometry. Analytical and Bioanalytical Chemistry 2009; 393: 1327-1336
4. Holčapek M, Kolářová L and Nobilis M. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Analytical and Bioanalytical Chemistry 2008; 391: 59-78.
5. Huang NK, Chern YJ, Fang JM, Lin CI, Chen WP and Lin YL. Neuroprotective principles from Gastrodia elata. Journal of Natural Products 2007; 70: 571-574.
6. Kima HJ, Moona KD, Ohb SY, Kimc SP and Leed SR. Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus. Neuroscience Letters 2001; 314: 65-68.
7. Liu ZH, Hu HT, Feng GF, Zhao ZY and Mao NY. Protective effects of gastrodin on the cellular model of Alzheimer's disease induced by Aβ 25-35. Journal of Sichuan University (Medical Science Edition) 2005; 36: 537-540.
8. Sun XH, Niu LJ, Li XQ, Lu XM and Li FM. Characterization of metabolic profile of mosapride citrate in rat identification of two new metabolites: mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2009; 50: 27-34.
9. Takáts Z, Wiseman JM, Gologan B and Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 2004; 306: 471-473.
10. Wang L, Xiao HB, Liang XM and Wei LX. Identification of phenolics and nucleoside derivatives in Gastrodia elata by HPLC-UV-MS. Journal of Seperation Science 2007; 30: 1488-1495.
11. Wang Q, Chen GS and Zeng S. Distribution and metabolism of gastrodin in rat brain. Journal of Pharmaceutical and Biomedical Analysis 2008a; 46: 399-404.
12. 2-receptor antagonist, lafutidine, in human liver microsomes by liquid chromatography coupled with ion trap mass spectrometry. Rapid Communications in Mass Spectrometry 2008b; 22: 1843-1852.